Michael Edward Kallen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Michael Edward Kallen has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
Rima Koka
Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA
11 shared publications- David Cella
Northwestern University, Evanston, USA
4 shared publications Zeba N. Singh
Department of Pathology University of Maryland School of Medicine Baltimore Maryland USA
4 shared publications- Maria R. Baer
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA
3 shared publications - Rima Koka
University of Maryland School of Medicine
3 shared publications Yi Ning
Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA
3 shared publications
Latest Publications
- Open Access
- 20 May 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (5) , 749
Natural Killer T Cell Function in Lymphoma Patients
Natural killer T (NKT) cells bridge innate and adaptive immune responses and play a critical role in anti-tumor immunity. The goal of the study was to assess NKT cell and T cell function in lymphoma patients and to investigate whether specific cytokines correlate with outcomes and/or immune cell function. Patient diagnoses were confirmed by histology. NKT and T cell number and function were assessed by flow cytometry and stimulation with artificial antigen-presenting cells (aAPCs) followed by ELISA and quantitative RT-PCR (qPCR). Cytokine expression levels were compared using online databases, and protein levels in the plasma were assessed by ELISA. NKT cell activation, indicated by at least 1.5-fold IFN-γ induction over baseline following stimulation, was detected in 82% of healthy donors, compared to 44% of lymphoma patients. Lymphoma patients have significantly higher levels of circulating pro- and anti-inflammatory cytokines IL-10, IL-6, and Sema4D as compared to healthy donors. In addition, NKT cell function in the blood correlated with NKT cell function in the bone marrow in lymphoma patients. We found that aAPC-qPCR can be used to quickly assess immune cell function in cancer patients. Circulating NKT cell function positively correlated with bone marrow NKT cell function, suggesting that circulating NKT responses reflect systemic immune competence. Outcome-associated transcriptomic analyses showed that lower expression of TGF-β, IL-6, IL-10, and IFN-γ mRNA correlated with poorer clinical outcomes, whereas higher Sema4D expression was associated with worse prognosis, identifying Sema4D as a potential immunologic biomarker linked to disease progression and immune dysfunction in B cell lymphoma.
- 20 May 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (5) , 749
Open AccessNatural Killer T Cell Function in Lymphoma Patients
Natural killer T (NKT) cells bridge innate and adaptive immune responses and play a critical role in anti-tumor immunity. The goal of the study was to assess NKT cell and T cell function in lymphoma patients and to investigate whether specific cytokines correlate with outcomes and/or immune cell function. Patient diagnoses were confirmed by histology. NKT and T cell number and function were assessed by flow cytometry and stimulation with artificial antigen-presenting cells (aAPCs) followed by ELISA and quantitative RT-PCR (qPCR). Cytokine expression levels were compared using online databases, and protein levels in the plasma were assessed by ELISA. NKT cell activation, indicated by at least 1.5-fold IFN-γ induction over baseline following stimulation, was detected in 82% of healthy donors, compared to 44% of lymphoma patients. Lymphoma patients have significantly higher levels of circulating pro- and anti-inflammatory cytokines IL-10, IL-6, and Sema4D as compared to healthy donors. In addition, NKT cell function in the blood correlated with NKT cell function in the bone marrow in lymphoma patients. We found that aAPC-qPCR can be used to quickly assess immune cell function in cancer patients. Circulating NKT cell function positively correlated with bone marrow NKT cell function, suggesting that circulating NKT responses reflect systemic immune competence. Outcome-associated transcriptomic analyses showed that lower expression of TGF-β, IL-6, IL-10, and IFN-γ mRNA correlated with poorer clinical outcomes, whereas higher Sema4D expression was associated with worse prognosis, identifying Sema4D as a potential immunologic biomarker linked to disease progression and immune dysfunction in B cell lymphoma.
- 26 March 2025
- Published by Springer Nature in Journal of Hematopathology
- Vol. 18 (1) , 1-3
Lifileucel (AMTAGVI) tumor-infiltrating lymphocyte morphology in CellaVision peripheral smear reviews
- 26 March 2025
- Published by Springer Nature in Journal of Hematopathology
- Vol. 18 (1) , 1-3
Lifileucel (AMTAGVI) tumor-infiltrating lymphocyte morphology in CellaVision peripheral smear reviews
- 19 September 2024
- Published by BMJ in Journal of Clinical Pathology
- Vol. 78 (3) , 208-211
Assessment of AI-based computational H&E staining versus chemical H&E staining for primary diagnosis in lymphomas: a brief interim report
Microscopic review of tissue sections is of foundational importance in pathology, yet the traditional chemistry-based histology laboratory methods are labour intensive, tissue destructive, poorly scalable to the evolving needs of precision medicine and cause delays in patient diagnosis and treatment. Recent AI-based techniques offer promise in upending histology workflow; one such method developed by PictorLabs can generate near-instantaneous diagnostic images via a machine learning algorithm. Here, we demonstrate the utility of virtual staining in a blinded, wash-out controlled study of 16 cases of lymph node excisional biopsies, including a spectrum of diagnoses from reactive to lymphoma and compare the diagnostic performance of virtual and chemical H&Es across a range of stain quality, image quality, morphometric assessment and diagnostic interpretation parameters as well as proposed follow-up immunostains. Our results show non-inferior performance of virtual H&E stains across all parameters, including an improved stain quality pass rate (92% vs 79% for virtual vs chemical stains, respectively) and an equivalent rate of binary diagnostic concordance (90% vs 92%). More detailed adjudicated reviews of differential diagnoses and proposed IHC panels showed no major discordances. Virtual H&Es appear fit for purpose and non-inferior to chemical H&Es in diagnostic assessment of clinical lymph node samples, in a limited pilot study.
- 19 September 2024
- Published by BMJ in Journal of Clinical Pathology
- Vol. 78 (3) , 208-211
Assessment of AI-based computational H&E staining versus chemical H&E staining for primary diagnosis in lymphomas: a brief interim report
Microscopic review of tissue sections is of foundational importance in pathology, yet the traditional chemistry-based histology laboratory methods are labour intensive, tissue destructive, poorly scalable to the evolving needs of precision medicine and cause delays in patient diagnosis and treatment. Recent AI-based techniques offer promise in upending histology workflow; one such method developed by PictorLabs can generate near-instantaneous diagnostic images via a machine learning algorithm. Here, we demonstrate the utility of virtual staining in a blinded, wash-out controlled study of 16 cases of lymph node excisional biopsies, including a spectrum of diagnoses from reactive to lymphoma and compare the diagnostic performance of virtual and chemical H&Es across a range of stain quality, image quality, morphometric assessment and diagnostic interpretation parameters as well as proposed follow-up immunostains. Our results show non-inferior performance of virtual H&E stains across all parameters, including an improved stain quality pass rate (92% vs 79% for virtual vs chemical stains, respectively) and an equivalent rate of binary diagnostic concordance (90% vs 92%). More detailed adjudicated reviews of differential diagnoses and proposed IHC panels showed no major discordances. Virtual H&Es appear fit for purpose and non-inferior to chemical H&Es in diagnostic assessment of clinical lymph node samples, in a limited pilot study.
- 17 September 2024
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 33 (3) , 670-672
Malignant Melanotic Nerve Sheath Tumor – A Pitfall in the Diagnosis of Schwannoma
- 17 September 2024
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 33 (3) , 670-672
Malignant Melanotic Nerve Sheath Tumor – A Pitfall in the Diagnosis of Schwannoma
- 21 August 2024
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 33 (3) , 666-669
AI-Based Computational H&E Staining Enables Spatial Transcriptomic Analysis in Classic Hodgkin Lymphoma
- 21 August 2024
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 33 (3) , 666-669
AI-Based Computational H&E Staining Enables Spatial Transcriptomic Analysis in Classic Hodgkin Lymphoma
- 13 June 2024
- Published by Springer Nature in Journal of Hematopathology
- Vol. 17 (3) , 175-177
AI-based computational H&E staining in lymphomas
- 13 June 2024
- Published by Springer Nature in Journal of Hematopathology
- Vol. 17 (3) , 175-177
AI-based computational H&E staining in lymphomas
- 12 June 2024
- Published by Springer Nature in Journal of Hematopathology
- Vol. 17 (4) , 231-233
Carvykti CAR T-cell morphology in cellavision peripheral smear reviews
- 12 June 2024
- Published by Springer Nature in Journal of Hematopathology
- Vol. 17 (4) , 231-233
Carvykti CAR T-cell morphology in cellavision peripheral smear reviews
- 6 May 2024
- Published by Wiley in Histopathology
- Vol. 85 (3) , 521-522
Lesson of the Month: perinephric myxoid pseudotumor of fat co‐occurring with polycystic kidney disease
- 6 May 2024
- Published by Wiley in Histopathology
- Vol. 85 (3) , 521-522
Lesson of the Month: perinephric myxoid pseudotumor of fat co‐occurring with polycystic kidney disease
- Open Access
- 5 April 2024
- Published by Springer Nature in Journal of Hematopathology
- Vol. 17 (2) , 49
In memorium: Dr. Zeba Singh
- 5 April 2024
- Published by Springer Nature in Journal of Hematopathology
- Vol. 17 (2) , 49
Open AccessIn memorium: Dr. Zeba Singh
- 22 December 2023
- Published by Wiley in British Journal of Haematology
- Vol. 204 (3) , 747-748
Macrophage activation syndrome after granulocyte colony‐stimulating factor in a patient with systemic lupus erythematosus
- 22 December 2023
- Published by Wiley in British Journal of Haematology
- Vol. 204 (3) , 747-748
Macrophage activation syndrome after granulocyte colony‐stimulating factor in a patient with systemic lupus erythematosus